Moreover, we observed the positive correlation between the expression of S1PR1 and CD68 (Figure 1G) and between IL-22R1 and CD68 (Figure 1H) in bone or brain metastases in breast cancer patients. This evidence concerns the gene S1PR1 and breast carcinoma.